Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy

Risk assessment for natalizumab-associated progressive multifocal leukoencephalopathy (Nat-PML) comprises the anti-JC virus (JCV) antibody index (AI). The anti-JCV AI was longitudinally determined in a natalizumab-treated MS cohort (Nat-MS, n = 468) and samples of Nat-PML patients (n = 15). In Nat-M...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmen, A., von Ahsen, N., Trampe, A.K., Hoepner, R., Plavina, T., Subramanyam, M., Kuesters, G., Gold, R., Chan, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433507/
https://www.ncbi.nlm.nih.gov/pubmed/28607714
http://dx.doi.org/10.1177/2055217316630008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433507/
https://www.ncbi.nlm.nih.gov/pubmed/28607714
http://dx.doi.org/10.1177/2055217316630008

Ejemplares similares